Psychiatry, Cannabis, Anesthesia, Cannabidiol and Episodic memory are his primary areas of study. His Psychiatry study incorporates themes from Recall and Audiology. As a part of the same scientific study, he usually deals with the Cannabis, concentrating on Psychosis and frequently concerns with Psychotomimetic, Dopamine and Pharmacology.
His studies deal with areas such as Placebo and Mood as well as Anesthesia. His Cannabidiol research includes elements of Dronabinol, Cannabinoid, Delta-9-tetrahydrocannabinol, Endocannabinoid system and Addiction. The concepts of his Episodic memory study are interwoven with issues in Ketamine, K-hole and Phencyclidine.
His primary areas of investigation include Psychiatry, Cannabis, Cannabidiol, Placebo and Developmental psychology. His work in Psychiatry tackles topics such as Audiology which are related to areas like Dissociative. His biological study spans a wide range of topics, including Young adult, Psychosis and Psychotomimetic.
As part of one scientific family, H. Valerie Curran deals mainly with the area of Cannabidiol, narrowing it down to issues related to the Endocannabinoid system, and often Cannabinoid receptor. His study in Placebo is interdisciplinary in nature, drawing from both Anesthesia, Abstinence and Internal medicine. He combines subjects such as Recall, Anger, Episodic memory and Cognitive bias with his study of Developmental psychology.
H. Valerie Curran mainly investigates Cannabis, Psychiatry, Cannabidiol, Psychotomimetic and Placebo. H. Valerie Curran has included themes like Psychosis, Cannabinoid and Clinical psychology in his Cannabis study. His study in the field of Medical cannabis, Depression, Episodic memory and Ketamine is also linked to topics like Recreation.
His study explores the link between Episodic memory and topics such as Working memory that cross with problems in Recall. The concepts of his Cannabidiol study are interwoven with issues in Functional magnetic resonance imaging, Neural correlates of consciousness, Effects of cannabis and Addiction, Craving. His Placebo research is multidisciplinary, relying on both MDMA, Empathy, Internal medicine, Abstinence and Prosocial behavior.
His primary areas of study are Cannabis, Cannabidiol, Psychiatry, Addiction and Craving. His Cannabis research includes elements of Cannabinoid, Pharmacology and Cannabinoid receptor. His Cannabidiol research focuses on subjects like Abstinence, which are linked to Interim analysis, Clinical trial, Randomized controlled trial, Clinical endpoint and Internal medicine.
The various areas that he examines in his Psychiatry study include Experimental model and Psychotomimetic. H. Valerie Curran has researched Psychotomimetic in several fields, including Working memory, Cannabinol, Tetrahydrocannabinol, Substance abuse and Effects of cannabis. H. Valerie Curran combines subjects such as Neurocognitive, Recall, Cannabis use and Schizophrenia with his study of Episodic memory.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
Celia J A Morgan;Tom P Freeman;Gráinne L Schafer;H Valerie Curran.
Neuropsychopharmacology (2010)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A.P. Bloomfield;Michael A.P. Bloomfield;Celia J.A. Morgan;Alice Egerton;Alice Egerton;Shitij Kapur.
Biological Psychiatry (2014)
In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users.
H. Valerie Curran;Lisa Monaghan.
Addiction (2001)
Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users
Suzanne L. Verheyden;John A. Henry;H. Valerie Curran.
Human Psychopharmacology-clinical and Experimental (2003)
Cannabidiol enhances consolidation of explicit fear extinction in humans
Ravi K. Das;Sunjeev K. Kamboj;Mayurun Ramadas;Kishoj Yogan.
Psychopharmacology (2013)
Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls
Celia J. A. Morgan;Leslie Muetzelfeldt;H. Valerie Curran.
Addiction (2009)
Can recreational doses of THC produce significant dopamine release in the human striatum
Paul R.A. Stokes;Mitul A. Mehta;Mitul A. Mehta;H. Valerie Curran;Gerome Breen.
NeuroImage (2009)
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Celia J.A. Morgan;Ravi K. Das;Alyssa Joye;H. Valerie Curran.
Addictive Behaviors (2013)
Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.
H. Valerie Curran;Fabrizio Schifano;Malcolm Lader.
Psychopharmacology (1991)
Selective impairment in the recognition of anger induced by diazepam.
Robert James Richard Blair;H. Valerie Curran.
Psychopharmacology (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Exeter
University of Bath
Imperial College London
King's College London
Imperial College London
King's College London
University of Queensland
King's College London
University of Cambridge
King's College London
Chinese Academy of Sciences
Microsoft (United States)
Chinese Academy of Sciences
Chinese Academy of Sciences
Peking University
Osaka University
University of Southern California
University of Western Brittany
University of the Basque Country
Stockholm University
University of Padua
University of Manitoba
The University of Texas Health Science Center at San Antonio
University of Regensburg
University of Alberta
Aarhus University